Login / Signup

Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel disease.

Antoine ChupinVittorio PerducaAntoine MeyerChristophe BellangerFranck CarbonnelCatherine Dong
Published in: Alimentary pharmacology & therapeutics (2020)
There is an increased risk of lymphoma in IBD patients treated with anti-TNF agents, either alone or when combined with thiopurines.
Keyphrases
  • patients with inflammatory bowel disease
  • diffuse large b cell lymphoma
  • rheumatoid arthritis